TrialBlood advances2019

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.

Jennifer S Whangbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.